NZ334568A - Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof - Google Patents

Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Info

Publication number
NZ334568A
NZ334568A NZ334568A NZ33456897A NZ334568A NZ 334568 A NZ334568 A NZ 334568A NZ 334568 A NZ334568 A NZ 334568A NZ 33456897 A NZ33456897 A NZ 33456897A NZ 334568 A NZ334568 A NZ 334568A
Authority
NZ
New Zealand
Prior art keywords
amino acid
nucleic acid
helicobacter pylori
vaccine compositions
acid sequences
Prior art date
Application number
NZ334568A
Inventor
Douglas Smith
Richard A Alm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NZ334568A publication Critical patent/NZ334568A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

An isolated nucleic acid comprising a nucleotide sequence encoding and H.pylori polypeptide comprising an amino acid sequence that has at least 60% homology with an amino acid sequence selected from the groups: Sequences 76, 98, 121, 83, 89, 118, 108, 110, 80, 112, 128, 91, 92, 101, 103, 125, 127, 129, 131, 74, 115, 87, 116, 84, 144, 90, 130, 78, 79, 81 and 94 as disclosed in the specification. Further claimed is a probe, recombinant expression vector, cell containing the vector, and method for producing an H.pylori polypeptide by culturing the cell containing the vector. Also claimed is a vaccine and use of the vaccine to treat Helicobacter pylori infection.
NZ334568A 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof NZ334568A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
NZ334568A true NZ334568A (en) 2000-04-28

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ334568A NZ334568A (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0716613B1 (en) * 1993-07-27 2003-07-09 Csl Limited Treatment of helicobacter associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
WO2000006743A2 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
EP2221365A1 (en) 2000-03-08 2010-08-25 Novozymes A/S Variants with altered properties
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
JP6078865B2 (en) * 2011-03-17 2017-02-15 国立大学法人三重大学 Antibody production method
JP6959937B2 (en) * 2015-12-14 2021-11-05 テクニシェ ユニバーシタット ミュンヘン Helicobacter pylori vaccine
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
AR009600A1 (en) 2000-04-26
SK34699A3 (en) 2000-04-10
AU5093398A (en) 1998-05-22
PL333169A1 (en) 1999-11-22
WO1998018323A1 (en) 1998-05-07
BR9712587A (en) 1999-10-26
SA98180918A (en) 2005-12-03
JP2001504329A (en) 2001-04-03
CA2265523A1 (en) 1998-05-07
NO991995D0 (en) 1999-04-27
NO991995L (en) 1999-06-28
ID22065A (en) 1999-08-26
IS5005A (en) 1999-03-18
TR199900940T2 (en) 1999-09-21
EE9900176A (en) 1999-12-15
CN1235513A (en) 1999-11-17
AU734052B2 (en) 2001-05-31
EP0973394A4 (en) 2005-03-30
KR20000052831A (en) 2000-08-25
IL129397A0 (en) 2000-02-17
EP0973394A1 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
RU2206611C2 (en) DNA FRAGMENT, PLASMID VECTOR, METHOD FOR PREPARING POLYPEPTIDE AND POLYPEPTIDE ELICITING IL-1β PROTEASE ACTIVITY
NZ331829A (en) Clostridium perfringens vaccines
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
NZ334568A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
ES2009238A6 (en) Mycobacterial recombinants and peptides
SG49097A1 (en) Nucleotide sequences coding for a protein with urease activity
GB8601597D0 (en) Nucleotide sequences
EP0305488A4 (en) Mycobacterial recombinants and peptides
ES8802182A1 (en) Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody.
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
ATE284954T1 (en) HYALURONAN SYNTHASE GENE AND ITS USE
ES8600783A1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, DNA sequence encoding it, vectors containing the sequence and host cells transformed thereby.
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
CA2266421A1 (en) Genes coding for a protein having glycoside transfer activity
HUP9904219A2 (en) Methods and compositions for delivery and expression of interferon-alfa-nucleic acids
EP0752888A4 (en) NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR
MX9603876A (en) Vacuolating toxin-deficient h. pylori and related methods.
EP0770137A4 (en) Improvements in production of proteins in host cells
YU200091A (en) AHASARE-RESISTANT MUTANT DELECTIONS IN HERBICIDES
DE69730814D1 (en) THE NUCA PROTEIN OF HAEMOPHILUS INFLUENZAE AND ITS CODING GENE
GR3020790T3 (en) Achromobacter protease I gene and gene product thereof
CA2145064A1 (en) Improvements in or relating to immune response modification
MXPA03010816A (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system.
Engström et al. Characterization of the N-terminal structure of pertussis toxin subunit S1 and hybridization of oligodeoxyribonucleotide probes with a Bordetella pertussis DNA fragment

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: AMENDMENT BY WAY OF DISCLAIMER BY DELETION OF CLAIMS 7 TO 9, 18 TO 25, 47 TO 53, 75, 79, 81 TO 82, AND BY WAY OF DELETION OF A CLAUSE

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended